Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Featured Company (BOS Manchester 2024)

CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative...
View profile

Featured Speaker (BOS Manchester 2024)

Observations and Challenges in Global Registration of a New Anti-Cancer Drug.

Dr Yasunori Abe, Manager, Taiho Pharmaceutical Co., Ltd.

ABSTRACT: Taiho Pharmaceutical Company, part of the Otsuka Group of Companies, is a mid-sized pharmaceutical company headquartered in Tokyo. The company is expanding its Global reach through a developing pipeline of innovative oncology products. Lytgobi® (Futibatinib), which is the subject of this presentation, is the first product that Taiho has marketed in the 3 major territories of the USA, Japan, and EU.

Our presentation will reflect on some observations and challenges we faced in achieving this global resignation. The first part will focus on the control of two Critical Quality Attributes... Click here to Read More